Werewolf Therapeutics (HOWL) Institutional Ownership $1.64 -0.03 (-1.80%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Werewolf Therapeutics (NASDAQ:HOWL)CurrentInstitutional OwnershipPercentage64.84%Number ofInstitutional Buyers(last 12 months)23TotalInstitutional Inflows(last 12 months)$20.31MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$1.43M Get HOWL Insider Trade Alerts Want to know when executives and insiders are buying or selling Werewolf Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HOWL Institutional Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Werewolf Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC54,810$116K0.0%+130.1%0.123% 11/16/2024 Geode Capital Management LLC685,989$1.45M0.0%+6.3%1.539% 11/15/2024 Barclays PLC54,810$116K0.0%+130.1%0.123% 11/15/2024 XTX Topco Ltd21,209$45K0.0%N/A0.048% 11/15/2024 Jane Street Group LLC15,149$32K0.0%-47.0%0.034% 11/15/2024 State Street Corp476,439$1.01M0.0%+12.4%1.069% Get the Latest News and Ratings for HOWL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Point72 Asset Management L.P.109,816$233K0.0%-70.5%0.246% 11/14/2024 PFM Health Sciences LP3,398,747$7.21M0.4%+4.9%7.627% 11/14/2024 Walleye Capital LLC108,968$231K0.0%+10.7%0.245% 10/3/2024 SG Americas Securities LLC13,517$29K0.0%N/A0.031% 9/16/2024 Point72 DIFC Ltd14,046$34K0.0%N/A0.032% 9/16/2024 Cubist Systematic Strategies LLC28,371$69K0.0%-30.2%0.065% 8/16/2024 Murchinson Ltd.62,500$152K0.0%N/A0.144% 8/15/2024 Millennium Management LLC1,110,298$2.71M0.0%+96.4%2.555% 8/14/2024 Cubist Systematic Strategies LLC28,371$69K0.0%-30.2%0.065% 8/14/2024 Murchinson Ltd.62,500$152K0.0%N/A0.144% 8/14/2024 Point72 DIFC Ltd14,046$34K0.0%N/A0.032% 8/14/2024 Marshall Wace LLP134,184$327K0.0%+410.5%0.309% 8/13/2024 Rubric Capital Management LP1,333,893$3.26M0.1%-17.7%3.070% 8/9/2024 Renaissance Technologies LLC171,000$417K0.0%+103.1%0.394% 8/9/2024 Dimensional Fund Advisors LP160,577$392K0.0%+43.9%0.370% 8/8/2024 American Century Companies Inc.37,634$92K0.0%+50.7%0.087% 8/6/2024 Acadian Asset Management LLC212,296$516K0.0%+22.8%0.489% 8/1/2024 Rhumbline Advisers32,547$79K0.0%N/A0.075% 7/26/2024 Bank of New York Mellon Corp67,644$165K0.0%N/A0.156% 5/16/2024 Janus Henderson Group PLC1,688,054$10.92M0.0%N/A3.884% 5/10/2024 Acadian Asset Management LLC172,883$1.12M0.0%+119.8%0.399% 5/10/2024 Vanguard Group Inc.1,107,347$7.18M0.0%+26.8%2.554% 5/9/2024 HBK Sorce Advisory LLC13,227$86K0.0%-50.0%0.031% 4/19/2024 Denali Advisors LLC26,600$172K0.1%N/A0.061% 2/15/2024 PFM Health Sciences LP3,468,177$13.39M0.8%+35.6%8.529% 2/14/2024 Lighthouse Investment Partners LLC22,472$87K0.0%N/A0.055% 2/5/2024 Certuity LLC10,000$39K0.0%N/A0.028% 2/1/2024Financial Perspectives Inc6,750$26K0.0%+80.0%0.019% 8/4/2023 HBK Sorce Advisory LLC26,454$81K0.0%-50.0%0.074% 5/15/2023 Rubric Capital Management LP1,935,357$5.03M0.1%+5.4%5.449% 5/8/2023 Bailard Inc.18,127$47K0.0%N/A0.051% 2/9/2023 Chicago Partners Investment Group LLC10,729$41K0.0%N/A0.035% 11/15/2022 PFM Health Sciences LP2,815,654$12.70M0.5%+62.7%9.158% 11/15/2022 Platinum Investment Management Ltd.109,530$494K0.0%-48.7%0.356% New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now!11/15/2022 Laurion Capital Management LP522,900$2.36M0.0%-2.3%1.700% 11/14/2022Ergoteles LLC114,595$517K0.0%-11.2%0.388% 11/14/2022 Rubric Capital Management LP966,879$4.36M0.2%+371.7%3.274% 10/25/2022 Denali Advisors LLC5,900$27K0.0%N/A0.020% 8/15/2022 Laurion Capital Management LP535,160$2.19M0.0%N/A1.935% 8/8/2022 Y Intercept Hong Kong Ltd11,124$45K0.0%N/A0.040% 7/27/2022 Bailard Inc.21,200$87K0.0%N/A0.077% 5/11/2022Granite Point Capital Management L.P.55,000$242K0.1%+266.7%0.199% 2/15/2022 Adage Capital Partners GP L.L.C.960,448$11.44M0.0%-2.5%3.483% 2/14/2022 Deerfield Management Company L.P. Series C958,125$11.41M0.2%-45.3%3.474% 2/14/2022 Soleus Capital Management L.P.64,585$769K0.1%-88.5%0.234% 2/11/2022Granite Point Capital Management L.P.15,000$179K0.0%N/A0.054% 2/8/2022 Northern Trust Corp200,065$2.38M0.0%+184.2%0.725% 11/15/2021 Deerfield Management Company L.P. Series C1,752,787$30.08M0.6%-31.3%6.358% 11/15/2021 Sphera Funds Management LTD.688,475$11.81M1.0%-2.5%2.497% 11/15/2021 Caas Capital Management LP162,599$2.79M0.1%+62.6%0.590% 11/12/2021 Geode Capital Management LLC136,472$2.34M0.0%+26.2%0.495% 11/10/2021 Levin Capital Strategies L.P.15,000$257K0.0%N/A0.054% 11/9/2021BlackRock Inc.369,961$6.35M0.0%+1.1%1.342% 11/9/2021 Platinum Investment Management Ltd.213,381$3.66M0.1%+3.1%0.774% 11/8/2021 Russell Investments Group Ltd.125,873$2.16M0.0%N/A0.457% 11/2/2021 New York State Common Retirement Fund14,765$253K0.0%+13.3%0.054% 8/23/2021 DC Funds LP589,102$10.27M48.8%N/A2.137% 8/17/2021 Sphera Funds Management LTD.706,294$12.05M0.8%N/A2.562% 8/17/2021 PFM Health Sciences LP400,000$6.98M0.2%N/A1.451% 8/17/2021 Aristides Capital LLC25,585$446K0.1%N/A0.093% 8/17/2021 Caas Capital Management LP100,000$1.74M0.0%N/A0.363% 8/16/2021 California State Teachers Retirement System10,465$183K0.0%N/A0.038% 8/16/2021 RA Capital Management L.P.4,291,881$74.85M1.2%N/A15.568% 8/16/2021 Alyeska Investment Group L.P.206,201$3.60M0.0%N/A0.748% 8/16/2021 Schonfeld Strategic Advisors LLC11,300$197K0.0%N/A0.041% 8/16/2021 Charles Schwab Investment Management Inc.16,038$280K0.0%N/A0.058% 8/16/2021 State Street Corp78,237$1.36M0.0%N/A0.284% 8/16/2021 Nuveen Asset Management LLC12,001$209K0.0%N/A0.044% 8/16/2021 Goldman Sachs Group Inc.37,435$653K0.0%N/A0.136% 8/13/2021 Northern Trust Corp75,774$1.32M0.0%N/A0.275% 8/13/2021 Geode Capital Management LLC108,178$1.89M0.0%N/A0.392% 8/13/2021 MPM Asset Management LLC4,284,172$74.72M13.9%N/A15.540% 8/13/2021 Vanguard Group Inc.173,127$3.02M0.0%N/A0.628% 8/13/2021 MPM Oncology Impact Management LP2,388,011$41.65M6.8%N/A8.662% 8/13/2021 FMR LLC315,000$5.49M0.0%N/A1.143% 8/12/2021 JPMorgan Chase & Co.9,352$163K0.0%N/A0.034% 8/11/2021 Arena Capital Advisors LLC CA14,958$261K0.0%N/A0.054% 8/11/2021 Bank of New York Mellon Corp22,213$387K0.0%N/A0.081% 8/11/2021BlackRock Inc.365,863$6.38M0.0%N/A1.327% 8/11/2021 Deutsche Bank AG4,492$78K0.0%N/A0.016% 8/10/2021 Nicholas Investment Partners LP294,654$5.14M0.3%N/A1.069% 8/10/2021 Citigroup Inc.2,016$35K0.0%N/A0.007% 8/4/2021 Migdal Insurance & Financial Holdings Ltd.187,500$3.27M0.0%N/A0.680% (Data available from 1/1/2016 forward) HOWL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HOWL shares? During the previous two years, 30 institutional investors and hedge funds held shares of Werewolf Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($10.92M), PFM Health Sciences LP ($7.21M), Vanguard Group Inc. ($7.18M), Rubric Capital Management LP ($3.26M), Millennium Management LLC ($2.71M), Geode Capital Management LLC ($1.45M), and State Street Corp ($1.01M).Learn more on HOWL's institutional investors. What percentage of Werewolf Therapeutics stock is owned by institutional investors? 64.84% of Werewolf Therapeutics stock is owned by institutional investors. Learn more on HOWL's institutional investor holdings. Which institutional investors have been buying Werewolf Therapeutics stock? Of the 26 institutional investors that purchased Werewolf Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($1.69M), PFM Health Sciences LP ($1.07M), Millennium Management LLC ($544.88K), Vanguard Group Inc. ($233.91K), Acadian Asset Management LLC ($133.63K), Murchinson Ltd. ($125K), and Marshall Wace LLP ($107.90K). How much institutional buying is happening at Werewolf Therapeutics? Institutional investors have bought a total of 4,568,980 shares in the last 24 months. This purchase volume represents approximately $20.64M in transactions. Which Werewolf Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Werewolf Therapeutics stock in the last 24 months: Rubric Capital Management LP ($287.14K), Point72 Asset Management L.P. ($261.86K), HBK Sorce Advisory LLC ($39.68K), Cubist Systematic Strategies LLC ($24.56K), and Jane Street Group LLC ($13.43K). How much institutional selling is happening at Werewolf Therapeutics? Institutional investors have sold a total of 626,670 shares in the last 24 months. This volume of shares sold represents approximately $1.51M in transactions. Related Companies Adicet Bio Major Shareholders Shattuck Labs Major Shareholders Xilio Therapeutics Major Shareholders Rani Therapeutics Major Shareholders Passage Bio Major Shareholders Curis Major Shareholders Nektar Therapeutics Major Shareholders Kodiak Sciences Major Shareholders ProQR Therapeutics Major Shareholders Immutep Major Shareholders This page (NASDAQ:HOWL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
